175 related articles for article (PubMed ID: 36585721)
1. Predicting immunoglobulin resistance in Kawasaki disease: an assessment of neutrophil to lymphocyte platelet ratio.
Lu Y; Tang Y; Wang B; Li X; Xu Q; Chu H; Lv H; Lu M; Qin Y
Ital J Pediatr; 2022 Dec; 48(1):208. PubMed ID: 36585721
[TBL] [Abstract][Full Text] [Related]
2. The combination of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as a novel predictor of intravenous immunoglobulin resistance in patients with Kawasaki disease: a multicenter study.
Kanai T; Takeshita S; Kawamura Y; Kinoshita K; Nakatani K; Iwashima S; Takizawa Y; Hirono K; Mori K; Yoshida Y; Nonoyama S
Heart Vessels; 2020 Oct; 35(10):1463-1472. PubMed ID: 32449049
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the predictive validity of the combination of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and other risk scoring systems for intravenous immunoglobulin (ivig)-resistance in Kawasaki disease.
Takeshita S; Kanai T; Kawamura Y; Yoshida Y; Nonoyama S
PLoS One; 2017; 12(5):e0176957. PubMed ID: 28542183
[TBL] [Abstract][Full Text] [Related]
4. Prediction of intravenous immunoglobulin resistance in Kawasaki disease in children.
Wu S; Liao Y; Sun Y; Zhang CY; Zhang QY; Yan H; Qi JG; Liu XQ; Chen YH; Wang YL; Li XY; Jin HF; Du JB
World J Pediatr; 2020 Dec; 16(6):607-613. PubMed ID: 32232677
[TBL] [Abstract][Full Text] [Related]
5. Prediction of intravenous immunoglobulin resistance in patients with Kawasaki disease according to the duration of illness prior to treatment.
Ha KS; Lee J; Lee KC
Eur J Pediatr; 2020 Feb; 179(2):257-264. PubMed ID: 31713683
[TBL] [Abstract][Full Text] [Related]
6. Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease.
Huang XB; Zhao S; Liu ZY; Xu YY; Deng F
Ann Med; 2023; 55(2):2264315. PubMed ID: 37870383
[TBL] [Abstract][Full Text] [Related]
7. The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study.
Zhang H; Cai J; Zhang R; Shuai S; Tang M; Ju R; Hu Y; Zuo T; Yang Y
J Int Med Res; 2024 May; 52(5):3000605241252115. PubMed ID: 38713460
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of albumin for intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients.
Zhang R; Shuai S; Zhang H; Cai J; Cui N; Tang M; Xing S; Gao Y; Liu X; Yang X
Ital J Pediatr; 2023 Jun; 49(1):78. PubMed ID: 37357258
[TBL] [Abstract][Full Text] [Related]
9. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.
Chantasiriwan N; Silvilairat S; Makonkawkeyoon K; Pongprot Y; Sittiwangkul R
Paediatr Int Child Health; 2018 Aug; 38(3):209-212. PubMed ID: 29768976
[TBL] [Abstract][Full Text] [Related]
10. The Combined Usefulness of the Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Predicting Intravenous Immunoglobulin Resistance with Kawasaki Disease.
Kawamura Y; Takeshita S; Kanai T; Yoshida Y; Nonoyama S
J Pediatr; 2016 Nov; 178():281-284.e1. PubMed ID: 27526622
[TBL] [Abstract][Full Text] [Related]
11. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
Xie T; Wang Y; Fu S; Wang W; Xie C; Zhang Y; Gong F
Pediatr Rheumatol Online J; 2017 Mar; 15(1):17. PubMed ID: 28320400
[TBL] [Abstract][Full Text] [Related]
12. [Values of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in predicting sensitivity to intravenous immunoglobulin in Kawasaki disease].
Yuan YD; Sun J; Li PF; Wei CL; Yu YH
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Apr; 19(4):410-413. PubMed ID: 28407827
[TBL] [Abstract][Full Text] [Related]
13. Value of C-reactive protein/albumin ratio in predicting intravenous immunoglobulin-resistant Kawasaki disease- a data from multi-institutional study in China.
Li G; Wang T; Gou Y; Zeng R; Liu D; Duan Y; Liu B
Int Immunopharmacol; 2020 Dec; 89(Pt A):107037. PubMed ID: 33242833
[TBL] [Abstract][Full Text] [Related]
14. Nomogram to predict risk of resistance to intravenous immunoglobulin in children hospitalized with Kawasaki disease in Eastern China.
Huang H; Jiang J; Shi X; Qin J; Dong J; Xu L; Huang C; Liu Y; Zheng Y; Hou M; Shen Q; Zeng B; Qian G; Yang F; Lv H
Ann Med; 2022 Dec; 54(1):442-453. PubMed ID: 35099338
[TBL] [Abstract][Full Text] [Related]
15. Value of neutrophil-lymphocyte ratio in predicting outcomes in Kawasaki disease.
Ha KS; Lee J; Jang GY; Lee J; Lee KC; Son CS; Lee JW
Am J Cardiol; 2015 Jul; 116(2):301-6. PubMed ID: 25975725
[TBL] [Abstract][Full Text] [Related]
16. Unique Molecular Patterns Uncovered in Kawasaki Disease Patients with Elevated Serum Gamma Glutamyl Transferase Levels: Implications for Intravenous Immunoglobulin Responsiveness.
Wang Y; Li Z; Hu G; Hao S; Deng X; Huang M; Ren M; Jiang X; Kanegaye JT; Ha KS; Lee J; Li X; Jiang X; Yu Y; Tremoulet AH; Burns JC; Whitin JC; Shin AY; Sylvester KG; McElhinney DB; Cohen HJ; Ling XB;
PLoS One; 2016; 11(12):e0167434. PubMed ID: 28002448
[TBL] [Abstract][Full Text] [Related]
17. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
Li W; He X; Zhang L; Wang Z; Wang Y; Lin H; Yuan J; Xie X; Qin Y; Huang P
Cardiovasc Ther; 2021; 2021():6660407. PubMed ID: 34239607
[TBL] [Abstract][Full Text] [Related]
18. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
Qiu H; He Y; Rong X; Ren Y; Pan L; Chu M; Wu R; Shi H
Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
[TBL] [Abstract][Full Text] [Related]
19. Association between serum miR-221-3p and intravenous immunoglobulin resistance in children with Kawasaki disease.
Jing F; Weng H; Pei Q; Zhang J; Liu R; Yi Q
Clin Exp Med; 2022 Nov; 22(4):621-628. PubMed ID: 35039938
[TBL] [Abstract][Full Text] [Related]
20. Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease.
Türkuçar S; Yıldız K; Acarı C; Dundar HA; Kır M; Ünsal E
Turk J Pediatr; 2020; 62(1):1-9. PubMed ID: 32253860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
